检索规则说明:AND代表“并且”;OR代表“或者”;NOT代表“不包含”;(注意必须大写,运算符两边需空一格)
检 索 范 例 :范例一: (K=图书馆学 OR K=情报学) AND A=范并思 范例二:J=计算机应用与软件 AND (U=C++ OR U=Basic) NOT M=Visual
作 者:路丽霞 张莹[1] 齐越鹏 任伟光[1] 李文聪[1] 高峰[3] 王荣琦[1] 南月敏[1] LU Lixia;ZHANG Ying;QI Yuepeng;REN Weiguang;LI Wencong;GAO Feng;WANG Rongqi;NAN Yuemin(Department of Hepatology of Integrated Traditional Chinese and Western Medicine,the Third Hospital of Hebei Medical University,Shijiazhuang,Hebei 050051,China;The Third School of Clinical Medicine,Hebei Medical University,Shijiazhuang,Hebei 050011,China;Department of Pathology,the Third Hospital of Hebei Medical University,Shijiazhuang,Hebei 050051,China)
机构地区:[1]河北医科大学第三医院中西医结合肝病科,河北石家庄050051 [2]河北医科大学第三临床医学系,河北石家庄050011 [3]河北医科大学第三医院病理科,河北石家庄050051
出 处:《中华实用诊断与治疗杂志》2025年第1期84-88,共5页Journal of Chinese Practical Diagnosis and Therapy
基 金:河北省卫生健康委医学科学研究课题计划指导性项目(20241667)。
摘 要:目的 总结肝细胞癌(HCC)以四肢骨转移为首发症状患者的临床特征,探讨其诊治经验。方法 2022年8月—2023年8月河北医科大学第三医院诊治2例以四肢骨转移为首发症状的HCC患者。例1以右下肢疼痛为首发症状,例2以右臀部、右大腿内侧间断疼痛为首发症状。2例经超声、MRI、CT、全身骨显像、活检或手术组织病理等检查诊断为HCC骨转移。例1行肝脏及骶骨动脉灌注化疗栓塞(TACE)治疗。例2行右髂骨病灶局部放射治疗后应用信迪利单抗+贝伐珠单抗靶向联合免疫治疗。结果 例1患者TACE术后症状减轻,后因病情进展死亡。例2患者局部放射治疗后症状减轻,规律行靶向联合免疫治疗出院后8个月肝脏肿瘤进展给予仑伐替尼联合肝内病灶姑息放疗,末次随访时病情稳定。结论 HCC首发症状为四肢骨转移临床少见,发现骨病灶后应尽早行影像学及组织病理检查明确原发病灶,及时行TACE、放射治疗、靶向及免疫治疗可延长患者生存期。Objective To summarize the clinical characteristics of hepatocellular carcinoma(HCC) patients with initial symptom of bone metastasis of extremities,and to explore the diagnosis and treatment experiences.Methods Two HCC patients with initial symptom of bone metastasis of extremities were treated in the Third Hospital of Hebei Medical University from August 2022 to August 2023.The initial symptom was right lower limb pain in patient 1,and intermittent right buttock and right inner thigh pain in patient 2.Both two patients were diagnosed with HCC bone metastasis by ultrasound,MRI,CT,whole-body bone scanning,biopsy,or surgical pathological examination.Patient 1 underwent transcatheter arterial chemoembolization(TACE) of liver and sacral artery,and patient 2 underwent local radiotherapy of right iliac bone lesion,followed by targeted therapy + immunotherapy with sintilimab + bevacizumab.Results Patient 1 experienced an alleviation in symptoms after TACE,and died of disease progression afterwards.Patient 2showed a relief of symptom after local radiotherapy,followed by regular targeted therapy + immunotherapy.Liver tumor progression occurred 8months after discharge,and lenvatinib combined with intrahepatic palliative radiotherapy was given.The latest follow-up showed a stable condition.Conclusions HCC rarely presents an initial symptom of bone metastasis of extremities.Once bone lesions are detected,an early imaging and pathological examinations should be conducted to identify the primary lesion,and timely TACE,radiotherapy,targeted therapy and immunotherapy can prolong the survival of patients.
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在链接到云南高校图书馆文献保障联盟下载...
云南高校图书馆联盟文献共享服务平台 版权所有©
您的IP:3.148.170.88